Kenneth Bate, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 33,120 shares at $480.24 ($16.0M) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Open-market sale of $16.0M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $480.24 | 1,763 | $847K | 5.3% |
| 2 | $480.24 | 1,763 | $847K | 5.3% |
| 3 | $481.13 | 3,259 | $1.6M | 9.8% |
| 4 | $481.13 | 3,259 | $1.6M | 9.8% |
| 5 | $482.41 | 1,284 | $619K | 3.9% |
| 6 | $482.41 | 1,284 |
| $619K |
| 3.9% |
| 7 | $483.41 | 2,069 | $1.0M | 6.2% |
| 8 | $483.41 | 2,069 | $1.0M | 6.2% |
| 9 | $484.78 | 1,931 | $936K | 5.8% |
| 10 | $484.78 | 1,931 | $936K | 5.8% |
| 11 | $485.54 | 1,008 | $489K | 3.1% |
| 12 | $485.54 | 1,008 | $489K | 3.1% |
| 13 | $486.73 | 827 | $403K | 2.5% |
| 14 | $486.73 | 827 | $403K | 2.5% |
| 15 | $487.49 | 2,775 | $1.4M | 8.4% |
| 16 | $487.49 | 2,775 | $1.4M | 8.4% |
| 17 | $489.09 | 696 | $340K | 2.1% |
| 18 | $489.09 | 696 | $340K | 2.1% |
| 19 | $489.95 | 933 | $457K | 2.8% |
| 20 | $489.95 | 933 | $457K | 2.8% |
| 21 | $490.98 | 30 | $15K | 0.1% |
| Total | $484.30 avg | 33,120 | $16.0M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $16.0M | — | Filing → |
| CBST | SELL | 2014-02-04 | $451K | — | Filing → |
| CBST | SELL | 2014-01-09 | $700K | — | Filing → |